Literature DB >> 28688150

National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.

Pratima Sharma1, Nathan P Goodrich2, Douglas E Schaubel3, Abigail R Smith2, Robert M Merion4,2.   

Abstract

Hospitalization is known to occur frequently in the first 6 months following liver transplantation (LT). Using a novel data linkage between the Scientific Registry of Transplant Recipients and Centers for Medicare and Medicaid Services, our study has 2 objectives: (1) to determine risk factors for "early" hospitalization (ie, within 6 months of LT); and (2) to quantify the importance of hospitalization history in the first 6 months with respect to subsequent patient survival (ie, survival, conditional on surviving 6 months post-LT). The study population consisted of patients aged ≥18 years who underwent deceased donor LT between January 1, 2003 and December 31, 2010, with Medicare as primary or secondary insurance and were discharged alive from the index LT hospitalization (n = 7220). The early hospitalization rate was 2.76 per patient-year and was significantly associated with many recipient factors (eg, recipient age, hepatitis C, diabetes, poor renal function including dialysis, and recipient of transjugular intrahepatic portosystemic shunt procedure before LT), as well as donor race and donation after cardiac death. Conditional on surviving 6 months after LT, the covariate-adjusted death rate increased by 22% for each additional hospitalization occurring in the first 6 months (hazard ratio, 1.22; P < 0.001). In conclusion, several LT recipient factors are significantly associated with early hospitalization. Moreover, a patient's hospitalization profile during follow-up months 0-6 is a very strong predictor of survival thereafter. Efforts and resources should be devoted toward identifying LT recipients at risk for early hospitalization and modifying the actionable risk factors such as hepatitis C, diabetes, and body mass index to improve resource utilization and overall outcomes. Liver Transplantation 23 1143-1152 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2017        PMID: 28688150      PMCID: PMC5568939          DOI: 10.1002/lt.24813

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  25 in total

1.  Clinical factors predicting readmission after orthotopic liver transplantation.

Authors:  Arema A Pereira; Renuka Bhattacharya; Robert Carithers; Jorge Reyes; James Perkins
Journal:  Liver Transpl       Date:  2012-09       Impact factor: 5.799

2.  Patient-specific prediction of ESRD after liver transplantation.

Authors:  Pratima Sharma; Nathan P Goodrich; Douglas E Schaubel; Mary K Guidinger; Robert M Merion
Journal:  J Am Soc Nephrol       Date:  2013-09-12       Impact factor: 10.121

3.  A prospective study of a protocol that reduces readmission after liver transplantation.

Authors:  Mark W Russo; David M Levi; Ruth Pierce; Vincent Casingal; Lon Eskind; Andrew deLemos; Paul A Schmeltzer; Philippe J Zamor
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

4.  The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.

Authors:  Phillip S Pang; Ahmad Kamal; Jeffrey S Glenn
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

5.  Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

Authors:  Michael Manns; Didier Samuel; Edward J Gane; David Mutimer; Geoff McCaughan; Maria Buti; Martín Prieto; José Luis Calleja; Markus Peck-Radosavljevic; Beat Müllhaupt; Kosh Agarwal; Peter Angus; Eric M Yoshida; Massimo Colombo; Mario Rizzetto; Hadas Dvory-Sobol; Jill Denning; Sarah Arterburn; Phillip S Pang; Diana Brainard; John G McHutchison; Jean-François Dufour; Hans Van Vlierberghe; Bart van Hoek; Xavier Forns
Journal:  Lancet Infect Dis       Date:  2016-02-18       Impact factor: 25.071

Review 6.  Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States.

Authors:  Susan Leppke; Tabitha Leighton; David Zaun; Shu-Cheng Chen; Melissa Skeans; Ajay K Israni; Jon J Snyder; Bertram L Kasiske
Journal:  Transplant Rev (Orlando)       Date:  2013-03-06       Impact factor: 3.943

7.  Report of a consensus conference on transplant program quality and surveillance.

Authors:  B L Kasiske; M A McBride; D L Cornell; R S Gaston; M L Henry; F D Irwin; A K Israni; N W Metzler; K W Murphy; A I Reed; J P Roberts; N Salkowski; J J Snyder; S C Sweet
Journal:  Am J Transplant       Date:  2012-06-08       Impact factor: 8.086

8.  Predictors of Early Hospitalization After Deceased Donor Liver Transplantation.

Authors:  Jessica Yu; Amy Hosmer; Tamara Parks; Christopher J Sonnenday; Pratima Sharma
Journal:  Dig Dis Sci       Date:  2015-06-30       Impact factor: 3.199

9.  OPTN/SRTR 2015 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2017-01       Impact factor: 8.086

10.  Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.

Authors:  Scott W Biggins; Kiran M Bambha; Norah A Terrault; John Inadomi; Stephen Shiboski; Jennifer L Dodge; Jane Gralla; Hugo R Rosen; John P Roberts
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

View more
  1 in total

1.  Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study.

Authors:  Uchenna Agbim; Anuj Sharma; Benedict Maliakkal; Saradasri Karri; Masahiko Yazawa; William Goldkamp; Pradeep S B Podila; Jason M Vanatta; Humberto Gonzalez; Miklos Z Molnar; Satheesh P Nair; James D Eason; Sanjaya K Satapathy
Journal:  Transplant Direct       Date:  2020-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.